speb/financial-data huggingface dataset:
CLLS balance_sheet (annual, 2022-12-31) — Common Stock: 2955000.00
CLLS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 117968000.00
CLLS cash_flow (annual, 2022-12-31) — Common Stock Payments: -569000.00
CLLS balance_sheet (annual, 2022-12-31) — Construction In Progress: 952000.00
CLLS income_statement (annual, 2022-12-31) — Cost Of Revenue: 8484000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 9421000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Assets: 143809000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 7872000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Debt: 4972000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 12844000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 538000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 59000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 59000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Liabilities: 62995000.00
CLLS balance_sheet (annual, 2022-12-31) — Current Provisions: 477000.00
CLLS cash_flow (annual, 2022-12-31) — Deferred Income Tax: 87000.00
CLLS cash_flow (annual, 2022-12-31) — Deferred Tax: 87000.00
CLLS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 18435000.00
CLLS income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 1887000.00
CLLS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 18435000.00
CLLS income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1887000.00
CLLS balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
CLLS income_statement (annual, 2022-12-31) — Diluted Average Shares: 45553219.00
CLLS income_statement (annual, 2022-12-31) — Diluted EPS: -2.33
CLLS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -106139000.00
CLLS income_statement (annual, 2022-12-31) — EBIT: -94813000.00
CLLS income_statement (annual, 2022-12-31) — EBITDA: -76378000.00
CLLS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -3360000.00
CLLS balance_sheet (annual, 2022-12-31) — Employee Benefits: 2390000.00
CLLS cash_flow (annual, 2022-12-31) — End Cash Position: 93216000.00
CLLS balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4716000.00
CLLS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1145000.00
CLLS balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -28605000.00
CLLS cash_flow (annual, 2022-12-31) — Free Cash Flow: -89885000.00
CLLS income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 6060000.00
CLLS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -28605000.00
CLLS income_statement (annual, 2022-12-31) — General And Administrative Expense: 8895000.00
CLLS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 718000.00
CLLS balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 772000.00
CLLS balance_sheet (annual, 2022-12-31) — Gross PPE: 163618000.00
CLLS income_statement (annual, 2022-12-31) — Gross Profit: 10687000.00
CLLS income_statement (annual, 2022-12-31) — Interest Expense: 3787000.00
CLLS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 3787000.00
CLLS income_statement (annual, 2022-12-31) — Interest Income: 1120000.00
CLLS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1120000.00
CLLS cash_flow (annual, 2022-12-31) — Interest Paid Cff: -332000.00
CLLS cash_flow (annual, 2022-12-31) — Interest Paid Cfo: 1158000.00
CLLS cash_flow (annual, 2022-12-31) — Interest Received Cfo: 1158000.00
CLLS balance_sheet (annual, 2022-12-31) — Inventory: 0.00
CLLS balance_sheet (annual, 2022-12-31) — Invested Capital: 136509000.00
CLLS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2761000.00
CLLS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 8791000.00
CLLS balance_sheet (annual, 2022-12-31) — Investments And Advances: 8791000.00
CLLS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5750000.00
CLLS balance_sheet (annual, 2022-12-31) — Land And Improvements: 17742000.00
CLLS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 49358000.00
CLLS balance_sheet (annual, 2022-12-31) — Long Term Debt: 13569000.00
CLLS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 62927000.00
CLLS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5750000.00
CLLS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -12354000.00
CLLS balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2390000.00
CLLS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 4914000.00
CLLS balance_sheet (annual, 2022-12-31) — Minority Interest: 7973000.00
CLLS income_statement (annual, 2022-12-31) — Minority Interests: 7894000.00
CLLS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -569000.00
CLLS cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -664000.00
CLLS income_statement (annual, 2022-12-31) — Net Income: -106139000.00
CLLS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -106139000.00
CLLS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -98688000.00
CLLS income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -15345000.00
CLLS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -106139000.00
CLLS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -90794000.00
CLLS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -98688000.00
CLLS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -114034000.00
CLLS cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -10000.00
CLLS income_statement (annual, 2022-12-31) — Net Interest Income: -14994000.00
CLLS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 126000.00
CLLS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -6604000.00
CLLS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -6604000.00
CLLS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -14994000.00
CLLS balance_sheet (annual, 2022-12-31) — Net PPE: 107897000.00
CLLS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2431000.00
CLLS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 117250000.00
CLLS balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2390000.00
CLLS income_statement (annual, 2022-12-31) — Normalized EBITDA: -82438000.00
CLLS income_statement (annual, 2022-12-31) — Normalized Income: -95339000.00
CLLS cash_flow (annual, 2022-12-31) — Operating Cash Flow: -87444000.00
CLLS cash_flow (annual, 2022-12-31) — Operating Gains Losses: 948000.00
CLLS income_statement (annual, 2022-12-31) — Operating Income: -89666000.00
CLLS income_statement (annual, 2022-12-31) — Operating Revenue: 19171000.00
CLLS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 45675968.00
CLLS balance_sheet (annual, 2022-12-31) — Other Current Assets: 538000.00
CLLS balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 4972000.00
CLLS balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 15680000.00
CLLS income_statement (annual, 2022-12-31) — Other Gand A: 1221000.00
CLLS income_statement (annual, 2022-12-31) — Other Income Expense: 6060000.00
CLLS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 718000.00
CLLS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 8627000.00
CLLS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 6963000.00
CLLS income_statement (annual, 2022-12-31) — Other Operating Expenses: -7930000.00
CLLS balance_sheet (annual, 2022-12-31) — Other Properties: 90589000.00
CLLS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 7907000.00
CLLS income_statement (annual, 2022-12-31) — Other Taxes: -6546000.00
CLLS balance_sheet (annual, 2022-12-31) — Payables: 24514000.00
CLLS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 33935000.00
CLLS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 6233000.00
CLLS income_statement (annual, 2022-12-31) — Pretax Income: -98600000.00
CLLS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CLLS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLLS cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 270000.00
CLLS cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -10000.00
CLLS cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
CLLS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2431000.00
CLLS balance_sheet (annual, 2022-12-31) — Receivables: 17574000.00
CLLS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 8484000.00
CLLS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 18435000.00
CLLS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -12354000.00
CLLS cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -569000.00
CLLS income_statement (annual, 2022-12-31) — Research And Development: 97501000.00
CLLS balance_sheet (annual, 2022-12-31) — Retained Earnings: -439504000.00
CLLS income_statement (annual, 2022-12-31) — Salaries And Wages: 7674000.00
CLLS cash_flow (annual, 2022-12-31) — Sale Of Investment: 126000.00
CLLS income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 3108000.00
CLLS income_statement (annual, 2022-12-31) — Selling General And Administration: 8895000.00
CLLS balance_sheet (annual, 2022-12-31) — Share Issued: 45675968.00
CLLS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 6043000.00
CLLS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 117968000.00
CLLS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 117250000.00
CLLS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 1515000.00
CLLS income_statement (annual, 2022-12-31) — Tax Provision: 87000.00
CLLS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.25
CLLS balance_sheet (annual, 2022-12-31) — Taxes Receivable: 16802000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Assets: 261216000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Capitalization: 131537000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Debt: 75771000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 125941000.00
CLLS income_statement (annual, 2022-12-31) — Total Expenses: 108837000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 135275000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 117406000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 72280000.00
CLLS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -89666000.00
CLLS income_statement (annual, 2022-12-31) — Total Other Finance Cost: 12327000.00
CLLS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 3058000.00
CLLS income_statement (annual, 2022-12-31) — Total Unusual Items: 6060000.00
CLLS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 6060000.00
CLLS balance_sheet (annual, 2022-12-31) — Working Capital: 80814000.00
CLLS income_statement (annual, 2023-12-31) — +Operating Expense: 90639000.00
CLLS income_statement (annual, 2023-12-31) — +Total Revenue: 755000.00
CLLS balance_sheet (annual, 2023-12-31) — Accounts Payable: 19069000.00
CLLS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 569000.00
CLLS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -75415000.00
CLLS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 522785000.00
CLLS balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CLLS balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
CLLS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 3197000.00
CLLS income_statement (annual, 2023-12-31) — Basic Average Shares: 57012815.00
CLLS income_statement (annual, 2023-12-31) — Basic EPS: -1.77
CLLS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 93216000.00
CLLS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 51863000.00
CLLS cash_flow (annual, 2023-12-31) — Capital Expenditure: -1073000.00
CLLS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 51450000.00
CLLS balance_sheet (annual, 2023-12-31) — Capital Stock: 4365000.00
CLLS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 136708000.00
CLLS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 203815000.00
CLLS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
CLLS balance_sheet (annual, 2023-12-31) — Cash Equivalents: 55000000.00
CLLS balance_sheet (annual, 2023-12-31) — Cash Financial: 81708000.00
CLLS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 81084000.00
CLLS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -15589000.00
CLLS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -21103000.00
CLLS cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 1781000.00
CLLS cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 79000.00
CLLS cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -3644000.00
CLLS cash_flow (annual, 2023-12-31) — Change In Account Payable: -6305000.00
CLLS cash_flow (annual, 2023-12-31) — Change In Inventory: 0.00
CLLS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 59149000.00
CLLS cash_flow (annual, 2023-12-31) — Change In Payable: -6305000.00
CLLS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -6305000.00
CLLS cash_flow (annual, 2023-12-31) — Change In Receivables: -3986000.00
CLLS cash_flow (annual, 2023-12-31) — Change In Working Capital: 48858000.00
CLLS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 2252000.00
CLLS cash_flow (annual, 2023-12-31) — Changes In Cash: 42608000.00
CLLS balance_sheet (annual, 2023-12-31) — Common Stock: 4365000.00
CLLS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 84695000.00
CLLS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 67936000.00
CLLS balance_sheet (annual, 2023-12-31) — Construction In Progress: 1271000.00
CLLS income_statement (annual, 2023-12-31) — Cost Of Revenue: 7419000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 9368000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Assets: 233006000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 8502000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Debt: 5162000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 13664000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 110325000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 110325000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Liabilities: 155144000.00
CLLS balance_sheet (annual, 2023-12-31) — Current Provisions: 1740000.00
CLLS cash_flow (annual, 2023-12-31) — Deferred Income Tax: 371000.00
CLLS cash_flow (annual, 2023-12-31) — Deferred Tax: 371000.00
CLLS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 18523000.00
CLLS income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 2012000.00
CLLS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 18523000.00
CLLS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 2012000.00
CLLS balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 7797000.00
CLLS income_statement (annual, 2023-12-31) — Diluted Average Shares: 57012815.00
CLLS income_statement (annual, 2023-12-31) — Diluted EPS: -1.77
CLLS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -101059000.00
CLLS income_statement (annual, 2023-12-31) — EBIT: -111160000.00
CLLS income_statement (annual, 2023-12-31) — EBITDA: -92637000.00
CLLS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 884000.00
CLLS balance_sheet (annual, 2023-12-31) — Employee Benefits: 2200000.00
CLLS cash_flow (annual, 2023-12-31) — End Cash Position: 136708000.00
CLLS balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4656000.00
CLLS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 82865000.00
CLLS balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -36690000.00
CLLS cash_flow (annual, 2023-12-31) — Free Cash Flow: -25819000.00
CLLS income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -16352000.00
CLLS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -36690000.00
CLLS income_statement (annual, 2023-12-31) — General And Administrative Expense: 8119000.00
CLLS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 672000.00
CLLS balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 569000.00
CLLS balance_sheet (annual, 2023-12-31) — Gross PPE: 168156000.00
CLLS income_statement (annual, 2023-12-31) — Gross Profit: -6664000.00
CLLS income_statement (annual, 2023-12-31) — Interest Expense: 5307000.00
CLLS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 5307000.00
CLLS income_statement (annual, 2023-12-31) — Interest Income: 3614000.00
CLLS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3614000.00
CLLS cash_flow (annual, 2023-12-31) — Interest Paid Cff: -333000.00
CLLS cash_flow (annual, 2023-12-31) — Interest Received Cfo: 3627000.00
CLLS balance_sheet (annual, 2023-12-31) — Invested Capital: 118301000.00
CLLS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -15510000.00
CLLS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 7853000.00
CLLS balance_sheet (annual, 2023-12-31) — Investments And Advances: 7853000.00
CLLS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 67936000.00
CLLS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 29671000.00
CLLS balance_sheet (annual, 2023-12-31) — Land And Improvements: 18544000.00
CLLS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 42948000.00
CLLS balance_sheet (annual, 2023-12-31) — Long Term Debt: 28444000.00
CLLS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 71392000.00
CLLS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 29671000.00
CLLS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -16191000.00
CLLS balance_sheet (annual, 2023-12-31) — Long Term Provisions: 2200000.00
CLLS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 4973000.00
CLLS balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
CLLS income_statement (annual, 2023-12-31) — Minority Interests: 7384000.00
CLLS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 67936000.00
CLLS cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 8000.00
CLLS income_statement (annual, 2023-12-31) — Net Income: -101059000.00
CLLS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -101059000.00
CLLS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -116835000.00
CLLS income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 8392000.00
CLLS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -101059000.00
CLLS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -109451000.00
CLLS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -116835000.00
CLLS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -108443000.00
CLLS cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
CLLS income_statement (annual, 2023-12-31) — Net Interest Income: -2812000.00
CLLS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -12874000.00
CLLS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 13480000.00
CLLS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 13480000.00
CLLS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2812000.00
CLLS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 1000.00
CLLS cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -1642000.00
CLLS balance_sheet (annual, 2023-12-31) — Net PPE: 92741000.00
CLLS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1073000.00
CLLS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 84023000.00
CLLS balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 158000.00
CLLS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 158000.00
CLLS balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2200000.00
CLLS income_statement (annual, 2023-12-31) — Normalized EBITDA: -76285000.00
CLLS income_statement (annual, 2023-12-31) — Normalized Income: -97187000.00
CLLS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -24746000.00
CLLS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 8000.00
CLLS income_statement (annual, 2023-12-31) — Operating Income: -97303000.00
CLLS income_statement (annual, 2023-12-31) — Operating Revenue: 755000.00
CLLS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 71751201.00
CLLS balance_sheet (annual, 2023-12-31) — Other Current Assets: 345000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 5162000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 978000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Equity Interest: 1000.00
CLLS income_statement (annual, 2023-12-31) — Other Gand A: 738000.00
CLLS income_statement (annual, 2023-12-31) — Other Income Expense: -16352000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 672000.00
CLLS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 17761000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: -1000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 12884000.00
CLLS income_statement (annual, 2023-12-31) — Other Operating Expenses: -7138000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Properties: 91505000.00
CLLS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 67107000.00
CLLS income_statement (annual, 2023-12-31) — Other Taxes: -6582000.00
CLLS balance_sheet (annual, 2023-12-31) — Payables: 19069000.00
CLLS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 28437000.00
CLLS balance_sheet (annual, 2023-12-31) — Prepaid Assets: 5716000.00
CLLS income_statement (annual, 2023-12-31) — Pretax Income: -116467000.00
CLLS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
CLLS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLLS cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1352000.00
CLLS cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
CLLS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -13363000.00
CLLS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1073000.00
CLLS balance_sheet (annual, 2023-12-31) — Receivables: 23130000.00
CLLS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 7419000.00
CLLS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 18523000.00
CLLS cash_flow (annual, 2023-12-31) — Repayment Of Debt: -16191000.00
CLLS income_statement (annual, 2023-12-31) — Research And Development: 87646000.00
CLLS balance_sheet (annual, 2023-12-31) — Retained Earnings: -405766000.00
CLLS income_statement (annual, 2023-12-31) — Salaries And Wages: 7381000.00
CLLS cash_flow (annual, 2023-12-31) — Sale Of Investment: 489000.00
CLLS income_statement (annual, 2023-12-31) — Selling General And Administration: 8119000.00
CLLS balance_sheet (annual, 2023-12-31) — Share Issued: 71751201.00
CLLS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5233000.00
CLLS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 84695000.00
CLLS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 84023000.00
CLLS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -4088000.00
CLLS income_statement (annual, 2023-12-31) — Tax Provision: 371000.00
CLLS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
CLLS balance_sheet (annual, 2023-12-31) — Taxes Receivable: 22561000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Assets: 334270000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Capitalization: 113139000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Debt: 85056000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 84695000.00
CLLS income_statement (annual, 2023-12-31) — Total Expenses: 98058000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 249575000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 101265000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 94431000.00
CLLS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -97302000.00
CLLS income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1119000.00
CLLS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
CLLS income_statement (annual, 2023-12-31) — Total Unusual Items: -16352000.00
CLLS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -16352000.00
CLLS balance_sheet (annual, 2023-12-31) — Working Capital: 77862000.00
CLLS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 100093635.00
CLLS income_statement (quarterly, 2024-09-30) — Basic EPS: -0.23
CLLS cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Investing Activities: 0.00
CLLS cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Operating Activities: 0.00
CLLS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 100093635.00
CLLS income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.23
CLLS balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 138000.00
CLLS income_statement (quarterly, 2024-09-30) — Minority Interests: 0.00
CLLS income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
CLLS balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 11120000.00
CLLS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 118000.00
CLLS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 118000.00
CLLS balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 926000.00
CLLS income_statement (quarterly, 2024-09-30) — Other Taxes: -1817000.00
CLLS income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 184000.00
CLLS income_statement (annual, 2024-12-31) — +Operating Expense: 91878000.00
CLLS income_statement (annual, 2024-12-31) — +Total Revenue: 41506000.00
CLLS balance_sheet (annual, 2024-12-31) — Accounts Payable: 18664000.00
CLLS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 6714000.00
CLLS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -91381000.00
CLLS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 494288000.00
CLLS balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CLLS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 2965000.00
CLLS income_statement (annual, 2024-12-31) — Basic Average Shares: 90566346.00
CLLS income_statement (annual, 2024-12-31) — Basic EPS: -0.41
CLLS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 136708000.00
CLLS balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 50913000.00
CLLS cash_flow (annual, 2024-12-31) — Capital Expenditure: -3843000.00
CLLS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 42630000.00
CLLS balance_sheet (annual, 2024-12-31) — Capital Stock: 5889000.00
CLLS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 143251000.00
CLLS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 260306000.00
CLLS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
CLLS balance_sheet (annual, 2024-12-31) — Cash Equivalents: 110336000.00
CLLS balance_sheet (annual, 2024-12-31) — Cash Financial: 32915000.00
CLLS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 89113000.00
CLLS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -102808000.00
CLLS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 22989000.00
CLLS cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
CLLS cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
CLLS cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
CLLS cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
CLLS cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: 0.00
CLLS cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: 0.00
CLLS cash_flow (annual, 2024-12-31) — Change In Account Payable: 2055000.00
CLLS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 5748000.00
CLLS cash_flow (annual, 2024-12-31) — Change In Payable: 2055000.00
CLLS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2055000.00
CLLS cash_flow (annual, 2024-12-31) — Change In Receivables: 45862000.00
CLLS cash_flow (annual, 2024-12-31) — Change In Working Capital: 53665000.00
CLLS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 52596000.00
CLLS cash_flow (annual, 2024-12-31) — Changes In Cash: 9295000.00
CLLS balance_sheet (annual, 2024-12-31) — Common Stock: 5889000.00
CLLS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 131033000.00
CLLS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 82822000.00
CLLS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: -1000.00
CLLS balance_sheet (annual, 2024-12-31) — Construction In Progress: 186000.00
CLLS income_statement (annual, 2024-12-31) — Cost Of Revenue: 9182000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 8830000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Assets: 287069000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 8385000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Debt: 4841000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 13226000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 112161000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 112161000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Liabilities: 166269000.00
CLLS balance_sheet (annual, 2024-12-31) — Current Provisions: 828000.00
CLLS cash_flow (annual, 2024-12-31) — Deferred Income Tax: -539000.00
CLLS cash_flow (annual, 2024-12-31) — Deferred Tax: -539000.00
CLLS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 19846000.00
CLLS income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1483000.00
CLLS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 19846000.00
CLLS income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1483000.00
CLLS balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 6010000.00
CLLS income_statement (annual, 2024-12-31) — Diluted Average Shares: 90566346.00
CLLS income_statement (annual, 2024-12-31) — Diluted EPS: -0.41
CLLS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -36761000.00
CLLS income_statement (annual, 2024-12-31) — EBIT: -29308000.00
CLLS income_statement (annual, 2024-12-31) — EBITDA: -9462000.00
CLLS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2752000.00
CLLS balance_sheet (annual, 2024-12-31) — Employee Benefits: 1115000.00
CLLS cash_flow (annual, 2024-12-31) — End Cash Position: 143251000.00
CLLS balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4556000.00
CLLS balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4556000.00
CLLS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 89113000.00
CLLS balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: -39537000.00
CLLS cash_flow (annual, 2024-12-31) — Free Cash Flow: 19146000.00
CLLS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 18968000.00
CLLS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -39537000.00
CLLS income_statement (annual, 2024-12-31) — General And Administrative Expense: 8420000.00
CLLS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1115000.00
CLLS balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 6714000.00
CLLS balance_sheet (annual, 2024-12-31) — Gross PPE: 167244000.00
CLLS income_statement (annual, 2024-12-31) — Gross Profit: 32324000.00
CLLS income_statement (annual, 2024-12-31) — Interest Expense: 7453000.00
CLLS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 7453000.00
CLLS income_statement (annual, 2024-12-31) — Interest Income: 11278000.00
CLLS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 11278000.00
CLLS cash_flow (annual, 2024-12-31) — Interest Paid Cff: -847000.00
CLLS cash_flow (annual, 2024-12-31) — Interest Received Cfo: 6558000.00
CLLS balance_sheet (annual, 2024-12-31) — Invested Capital: 179864000.00
CLLS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -102808000.00
CLLS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 7521000.00
CLLS balance_sheet (annual, 2024-12-31) — Investments And Advances: 7521000.00
CLLS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 82822000.00
CLLS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -1000.00
CLLS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 23201000.00
CLLS cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 6884000.00
CLLS balance_sheet (annual, 2024-12-31) — Land And Improvements: 18139000.00
CLLS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 34245000.00
CLLS balance_sheet (annual, 2024-12-31) — Long Term Debt: 43990000.00
CLLS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 78235000.00
CLLS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 23201000.00
CLLS cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 6884000.00
CLLS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -16063000.00
CLLS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 5100000.00
CLLS income_statement (annual, 2024-12-31) — Minority Interests: 0.00
CLLS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
CLLS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 82822000.00
CLLS cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -1000.00
CLLS cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -308000.00
CLLS income_statement (annual, 2024-12-31) — Net Income: -36761000.00
CLLS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -36761000.00
CLLS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -36761000.00
CLLS income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
CLLS income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
CLLS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -36761000.00
CLLS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -36761000.00
CLLS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -36761000.00
CLLS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -36761000.00
CLLS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -1260000.00
CLLS cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -1195000.00
CLLS income_statement (annual, 2024-12-31) — Net Interest Income: 3825000.00
CLLS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -98964000.00
CLLS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 7138000.00
CLLS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 7138000.00
CLLS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 3825000.00
CLLS cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -1000.00
CLLS cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -2000.00
CLLS balance_sheet (annual, 2024-12-31) — Net PPE: 75863000.00
CLLS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -2583000.00
CLLS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 129918000.00
CLLS balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 382000.00
CLLS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
CLLS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
CLLS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 382000.00
CLLS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CLLS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CLLS balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1115000.00
CLLS income_statement (annual, 2024-12-31) — Normalized EBITDA: -28430000.00
CLLS income_statement (annual, 2024-12-31) — Normalized Income: -55729000.00
CLLS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 22989000.00
CLLS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -287000.00
CLLS income_statement (annual, 2024-12-31) — Operating Income: -59554000.00
CLLS income_statement (annual, 2024-12-31) — Operating Revenue: 41506000.00
CLLS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 72093873.00
CLLS balance_sheet (annual, 2024-12-31) — Other Current Assets: 298000.00
CLLS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 4841000.00
CLLS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 12544000.00
CLLS income_statement (annual, 2024-12-31) — Other Gand A: 927000.00
CLLS income_statement (annual, 2024-12-31) — Other Income Expense: 18968000.00
CLLS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1115000.00
CLLS cash_flow (annual, 2024-12-31) — Other Non Cash Items: -20785000.00
CLLS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 11595000.00
CLLS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 882000.00
CLLS income_statement (annual, 2024-12-31) — Other Operating Expenses: -8561000.00
CLLS balance_sheet (annual, 2024-12-31) — Other Properties: 92906000.00
CLLS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 117055000.00
CLLS balance_sheet (annual, 2024-12-31) — Payables: 18680000.00
CLLS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 27510000.00
CLLS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 3428000.00
CLLS income_statement (annual, 2024-12-31) — Pretax Income: -36761000.00
CLLS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CLLS cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -1875000.00
CLLS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -1260000.00
CLLS cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -1195000.00
CLLS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -162770000.00
CLLS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -2583000.00
CLLS balance_sheet (annual, 2024-12-31) — Receivables: 23037000.00
CLLS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 9182000.00
CLLS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 19846000.00
CLLS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -16063000.00
CLLS income_statement (annual, 2024-12-31) — Research And Development: 90536000.00
CLLS balance_sheet (annual, 2024-12-31) — Retained Earnings: -329607000.00
CLLS income_statement (annual, 2024-12-31) — Salaries And Wages: 7493000.00
CLLS cash_flow (annual, 2024-12-31) — Sale Of Investment: 63806000.00
CLLS income_statement (annual, 2024-12-31) — Selling General And Administration: 8420000.00
CLLS balance_sheet (annual, 2024-12-31) — Share Issued: 72093873.00
CLLS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3167000.00
CLLS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 131033000.00
CLLS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 129918000.00
CLLS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLLS income_statement (annual, 2024-12-31) — Tax Provision: 0.00
CLLS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CLLS balance_sheet (annual, 2024-12-31) — Taxes Receivable: 16323000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Assets: 383544000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Capitalization: 175023000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Debt: 91461000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 131033000.00
CLLS income_statement (annual, 2024-12-31) — Total Expenses: 101060000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 252511000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 96476000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 86242000.00
CLLS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -59554000.00
CLLS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 16000.00
CLLS income_statement (annual, 2024-12-31) — Total Unusual Items: 18968000.00
CLLS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 18968000.00
CLLS balance_sheet (annual, 2024-12-31) — Working Capital: 120800000.00
CLLS income_statement (quarterly, 2025-03-31) — +Operating Expense: 22819000.00
CLLS income_statement (quarterly, 2025-03-31) — +Total Revenue: 10655000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 17209000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7870000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -97839000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 495266000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
CLLS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 2015000.00
CLLS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 100156559.00
CLLS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.18
CLLS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 143251000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 51802000.00
CLLS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -395000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 41000000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 5900000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 127636000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 241691000.00
CLLS cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
CLLS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 91510000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 36126000.00
CLLS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4091000.00
CLLS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 4222000.00
CLLS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -17158000.00
CLLS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -6289000.00
CLLS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -3363000.00
CLLS cash_flow (quarterly, 2025-03-31) — Change In Payable: -6289000.00
CLLS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -6289000.00
CLLS cash_flow (quarterly, 2025-03-31) — Change In Receivables: -1567000.00
CLLS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -11219000.00
CLLS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -230000.00
CLLS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -17027000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Common Stock: 5900000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 116204000.00
CLLS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CLLS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 848000.00
CLLS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2015000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 5360000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Assets: 271824000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 7862000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Debt: 5039000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 12901000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 113304000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 113304000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 162566000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 843000.00
CLLS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
CLLS cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
CLLS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 4931000.00
CLLS income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 353000.00
CLLS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 4931000.00
CLLS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 353000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 4458000.00
CLLS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 100156559.00
CLLS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.18
CLLS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -18128000.00
CLLS income_statement (quarterly, 2025-03-31) — EBIT: -16216000.00
CLLS income_statement (quarterly, 2025-03-31) — EBITDA: -11285000.00
CLLS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1412000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 1139000.00
CLLS cash_flow (quarterly, 2025-03-31) — End Cash Position: 127636000.00
CLLS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4090000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -37271000.00
CLLS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -17555000.00
CLLS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -4949000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -37271000.00
CLLS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2333000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 242000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 7870000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 170772000.00
CLLS income_statement (quarterly, 2025-03-31) — Gross Profit: 8640000.00
CLLS income_statement (quarterly, 2025-03-31) — Interest Expense: 1911000.00
CLLS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1911000.00
CLLS income_statement (quarterly, 2025-03-31) — Interest Income: 2912000.00
CLLS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2912000.00